Goldman Sachs Downgrades Aetna (AET) to Sell
Tweet
Share
E-mailGet Alerts AET Hot Sheet
Price: $212.70 --0%
Rating Summary:
10 Buy, 15 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Rating Summary:
10 Buy, 15 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Join SI Premium – FREE
Goldman Sachs downgraded Aetna (NYSE: AET) from Neutral to Sell with a price target of $45 (down from $50).
The firm said "we now see somewhat greater near-term downside risk to commercial margins following 1Q result."
For an analyst ratings summary and ratings history on Aetna click here. For more ratings news on Aetna click here.
Shares of Aetna closed at $43.05 yesterday.
The firm said "we now see somewhat greater near-term downside risk to commercial margins following 1Q result."
For an analyst ratings summary and ratings history on Aetna click here. For more ratings news on Aetna click here.
Shares of Aetna closed at $43.05 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Marvell (MRVL) PT Raised to $225 at TD Cowen
- SmartFinancial (SMBK) PT Raised to $60 at Benchmark on Higher Valuation
- Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $55 at H.C. Wainwright
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
